HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER
Clinical trials for HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER trials appear
Sign up with your email to follow new studies for HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in early ovarian cancer trial
Disease control CompletedThis pilot study tested whether adding the immunotherapy drugs nivolumab (with or without ipilimumab) to standard chemotherapy could be safe for people with advanced high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. 27 participants received the drug combina…
Matched conditions: HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New cancer drug karonudib tested for first time in humans
Disease control CompletedThis early-phase trial tested a new drug, Karonudib, in 63 people with advanced solid tumors that had not responded to standard treatments. The main goal was to check the drug's safety and find the best dose. Researchers also looked at how the drug moves through the body and any …
Matched conditions: HIGH-GRADE SEROUS FALLOPIAN TUBE CANCER
Phase: PHASE1 • Sponsor: Thomas Helleday Foundation • Aim: Disease control
Last updated Jun 26, 2026 15:08 UTC